Plants Standardized phytosubstance production is the key that unlocks the door to phytopharmaceuticals.

The foundation of plant based medicine.

  • Environmentally Controlled Biosphere

  • Manufacturing & Processing Standardized Phyto-Compounds

IP creation through environmental recipe.

  • Environmentally Modified Organism Enhancement in Proprietary Chamber System

  • Chemovar Propagation Research

New phyto-substances with incredible health benefits are being discovered daily, and our production methods are the key to unlock their potential as global medicines. These new discoveries, together with rapid technological advances in novel delivery methods, are at the forefront of a phyto-based healthcare revolution.

With meticulous research, obsessive standardization techniques and a passionate, driven team, we intend to revolutionize the medical industry.

 

“The World Health Organization (WHO) estimates that 80 percent of the world’s population still uses traditional remedies, including plants, as their primary health care tools.”

Standardization Of Production

For plant material to be considered medicine the industry must address the basic pharmaceutical principles:

  • Consistent standardized cannabinoid profiles of raw material within acceptable parameters +/- 10%

  • Pesticide and contaminant free production

Standardization means the ability to completely control the growth and production process to ensure consistency of each active compound within every batch:

  • This allows metered dosing with consistent efficacy from batch to batch guaranteeing a standardized delivery of active components with every dosage

  • Standardized cannabinoids combined with true metered dose delivery will allow for clinical trials which will lead to acceptance of this medicine in the medical community

This has still to be done consistently and economically. The Kensana team is the group with the collective knowledge to produce a consistent standardized product that meets stringent demands:

  • Proven and Innovative allowing for highly standardized production in the industry

  • Planned pharma-grade GMP facility, capable of meeting regulatory standards in relevant jurisdictions

Phyto Production Capabilities

PhytoGro

PhytoGro specializes in computer-controlled environmental systems and precisely controlled cultivation.

COMPUTER-CONTROLLED ENVIRONMENTAL SYSTEM

Our system can replicate the natural environment of any geographical location for a product that is both superior in quality and repeatable from batch to batch. We use custom, scalable growing chambers with proprietary LED lighting, which we can replicate anywhere in the world

Organic fertilizers and soil media, with no pesticides, permit us to deliver products which are natural and safe. A clean, strictly controlled indoor environment eliminates the need for pesticide applications. The final product is free of chemical toxins, to ensure maximum therapeutic benefit.

Our pharma grade, GMP facility will be capable of meeting regulatory standards in any jurisdiction. This proven and innovative technology facilitates the most standardized growth in the industry.

PRECISELY CONTROLLED CULTIVATION

For plants or plant material to be considered medicine the industry must address the basic pharmaceutical principles:

Consistent standardized cannabinoid profiles of raw material within acceptable parameters +/- 10%

Metered dosing with consistent efficacy batch to batch

Standardization means the ability to completely control the growth and production process to ensure consistency of each active compound with every batch. No one has done this consistently or economically before. The Phytogro founders have successfully proven out this model. The team is the only group with the collective knowledge to produce a consistent standardized product that meets stringent demands.

Proven and Innovative allowing for the most standardized growth in the industry

Pharma grade, GMP Facility capable of meeting regulatory standards in any jurisdiction

That is how we provide consistent and standardized products in each geographic area in all forms both flower and oils.

Partners With Deep Roots

Martin Bauer Group

  • MBG dates back to 1930 and includes an extraction portfolio of more than 200 different plants from over 80 countries. The selection covers Phyto-pharmaceutical extracts as well as extracts for food supplements.

  • By combining Martin Bauer Group’s Expertise as one of the world’s largest producers of plant based GMP pharmaceutical API’s and food with Kensana’s strengths in proven R&D and standardized production of cannabinoids we plan to create strategic alliances at a global level to achieve our vision.